Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

4.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.8K
Cross-bridge Cycle01:26

Cross-bridge Cycle

117.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics and Mechanism of the Enantioselective Passerini Multicomponent Reaction Catalyzed by Chiral Ionic Liquids.

ACS omega·2026
Same author

A DFT-Based Protocol for Modeling the Structure and Reactivity of Gold(III) Complexes.

Journal of computational chemistry·2025
Same author

Aqueous-Phase Multicomponent Reaction Mechanism for the Synthesis of Pyrido[2,3‑<i>d</i>]pyrimidines: A Theoretical Perspective.

ACS omega·2025
Same author

S-Se oxidative addition to auranofin derivatives: a DFT study.

Physical chemistry chemical physics : PCCP·2024
Same author

Translocation Processes of Pt(II)-Based Drugs through Human Breast Cancer Cell Membrane: <i>In Silico</i> Experiments.

Journal of chemical information and modeling·2023
Same author

Modeling the Cellular Uptake of Functionalized Carbon Nanohorns Loaded with Cisplatin through a Breast Cancer Cell Membrane.

Molecular pharmaceutics·2023

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Exploring Orofacial Muscle Regeneration &#8211; Insights and Innovations
06:33

Author Spotlight: Exploring Orofacial Muscle Regeneration – Insights and Innovations

Published on: December 29, 2023

778

Exploring the Myostatin Activation Pathway: A Promising Target for Treating Muscle Atrophy.

Daniel B Quintanilha1, Hélio F Dos Santos1

  • 1Núcleo de Estudos em Química Computacional - Federal University of Juiz de Fora, Juiz de Fora, MG 36.036-900, Brazil.

Journal of Chemical Information and Modeling
|June 12, 2025
PubMed
Summary
This summary is machine-generated.

Researchers explored myostatin

More Related Videos

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.1K
Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants
06:53

Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants

Published on: October 15, 2019

17.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Exploring Orofacial Muscle Regeneration &#8211; Insights and Innovations
06:33

Author Spotlight: Exploring Orofacial Muscle Regeneration – Insights and Innovations

Published on: December 29, 2023

778
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.1K
Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants
06:53

Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants

Published on: October 15, 2019

17.2K

Area of Science:

  • Biochemistry and molecular biology
  • Muscle physiology and regeneration

Background:

  • Myostatin, a muscle-specific protein, inhibits muscle growth.
  • High myostatin levels correlate with muscle atrophy, a key feature of muscular dystrophies.
  • Targeting myostatin offers potential for muscle regeneration therapies.

Purpose of the Study:

  • To investigate the molecular interactions governing myostatin activation.
  • To develop a computational model for peptide-based myostatin inhibitors.
  • To identify novel therapeutic targets for muscle growth promotion.

Main Methods:

  • Molecular dynamics simulations to model myostatin precursor interactions.
  • Analysis of key amino acid residues (e.g., Ile, Leu) involved in stabilization.
  • Identification of potential drug target sites through computational modeling.

Main Results:

  • The forearm domain of the myostatin precursor is crucial for maintaining its inactive state.
  • Specific residues like Isoleucine and Leucine are vital for this stabilization.
  • A novel inhibitory target site was discovered during the final activation stage.

Conclusions:

  • A peptide-based drug model targeting myostatin's essential residues and mutable sites was proposed.
  • The newly identified target site presents a promising avenue for small molecule inhibitor development.
  • These findings could lead to new therapeutic strategies for muscle wasting conditions.